new oral glp 1 agonist Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Danuglipron: An Oral GLP-1R Agonist

Description

Suspected pancreatitis during GLP-1 treatment requires permanent discontinuation of the medication and reporting via the Yellow Card Scheme

McIntosh recommends using a backup form of birth control during those weeks, such as condoms or a vaginal diaphragm, to avoid pregnancy

Best practice reminders Consistency is key: For best results, consistent daily use is recommended

The best candidates are usually individuals aged 55 or older who have at least two cardiovascular risk factors such as obesity, high blood pressure, smoking, high cholesterol, or protein in the urine or those already diagnosed with atherosclerotic cardiovascular disease

Impact on consumer goods These medications, primarily known for their efficacy in weight management, could have far-reaching consequences that could reshape consumer behavior across industries